Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for KINERET
- Hyperinsulinemia in Prediabetes Mediated by Interleukin-1β
- A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)
- Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia
- Anakinra for Preterm Infants Pilot
- Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart Failure
- Discovery and Analytical Validation of Inflammatory Bio-signatures of the Human Pain Experience
- Personalized Immunotherapy in Sepsis
- MIS-C Comparative Effectiveness Study
- Studying Anakinra to Reduce Secondary Brain Damage After Spontaneous Haemorrhagic Stroke
- Anakinra in Previously Untreated Chronic Lymphocytic Leukemia Patients
- suPAR-Guided Anakinra Treatment for Management of Severe Respiratory Failure by COVID-19
- A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment
- SCIL-1Ra in COVID-19 Feasibility & PK/PD
- Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS)
- Anakinra for the Reduction of CAR-T Toxicity in Patients With Relapsed or Refractory Large B-cell Lymphoma
- Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation
- suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE)
- Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction
- IL-1-receptor Antagonist During Cephalic Phase of Insulin Secretion in Health and Type 2 Diabetes
- Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma
- IL-1 Receptor Inhibitor for Granulomatous Complications in Patients With Chronic Granulomatous Disease
- Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial
- Anakinra as a Rescue Treatment for Allergic Inflammation
- Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis
- Pilot Study of the IL-1 Antagonist Anakinra for the Treatment of Endometriosis Related Symptoms
- Biologic Therapy to Prevent Osteoarthritis After ACL Injury
- BLOC-ICH: Interleukin-1 Receptor Antagonist in Intracerebral Haemorrhage
- Personalized Therapies in Inflammatory Complex Disease
- Pilot Study of Dapansutrile Capsules in Schnitzler's Syndrome
- Effects of Anakinra in Subjects With Autoimmune Inner Ear Disease
- Effects of Interleukin-1 Receptor Antagonism on Hyperandrogenemia in Women With Polycystic Ovary Syndrome
- A Trial of Validation and Restoration of Immune Dysfunction in Severe Infections and Sepsis
- A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Still's Disease (SJIA and AOSD)
- Anakinra: Safety and Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT
- Treatment of Acute Pericarditis With Anakinra
- Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)
- Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With Advanced Chronic Kidney Disease
- Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension
- Anakinra Versus Placebo for the Treatment of Acute MyocarditIS
- A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Acute Gouty Arthritis
- IL-1RA Treatment in Patients With Acute ACL Tear and Painful Effusions
- Role of Interleukin (IL)-1 in Postprandial Fatigue - The Chäschüechli 2 Study
- Kineret in the Treatment of Rheumatoid Arthritis
- Treatment of Macrophage Activation Syndrome (MAS) With Anakinra
- Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic Syndrome
- Anakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility Study
- Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer
- Interleukin-1 Receptor Antagonist for the Treatment of Heart Failure in Patients With Left Ventricular Assist Devices
- Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma
- Study of the Effects of Anakinra in Corticosteroid-resistant Subjects With Sudden Sensorineural Hearing Loss
- Anakinra and Kawasaki Disease
- Kineret CAPS Post Authorisation Study
- Clinical Study to Evaluate the Efficacy of Anakinra in Patients With Rheumatoid Arthritis and Diabetes
- Anakinra in Infants and Children With Coronary Artery Abnormalities in Acute Kawasaki Disease
- Interleukin-1 Blockade in HF With Preserved EF
- Cytokine Inhibition in Chronic Fatigue Syndrome Patients
- A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy
- Effects of Intraarticular IL1-Ra on Pain and Inflammatory Mediators After Knee Arhroscopy
- Interleukin-1 (IL-1) Blockade in Acute Myocardial Infarction (VCU-ART3)
- Role of Interleukin-1 in Postprandial Fatigue - The Cheesecake Study
- Efficacy Study of Anakinra, Pentoxifylline, and Zinc Compared to Methylprednisolone in Severe Acute Alcoholic Hepatitis
- Rilonacept for Deficiency of the Interleukin-1 Receptor Antagonist (DIRA)
- Anakinra for Inflammatory Pustular Skin Diseases
- Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever
- Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers
- Pilot Feasibility Study of the Safety and Efficacy of Anakinra in Heart Failure With Preserved Ejection Fraction
- Immunomodulation, IL-1 Inhibition, and Postoperative Incisional Pain
- Effect of Anakinra on Insulin Sensitivity in Type 1 Diabetes Mellitus
- The Effect of Anakinra on Insulin Secretion
- A Clinical Trial of Anakinra for Steroid-Resistant Autoimmune Inner Ear Disease
- A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease
- Anakinra to Prevent Adverse Post-infarction Remodeling (2)
- A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis
- Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study
- Interleukin-1 Receptor Antagonist and Insulin Sensitivity
- Topical IL-1-Ra for Treatment of Corneal Neovascularization
- Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis
- Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis
- Anti-Interleukin-1 in Diabetes Action
- Fatigue and Interleukin-1 (IL-1) Blockade in Primary Sjøgrens Syndrome
- Anti-inflammatory Therapy With Anakinra in Newly Diagnosed Type 1 Diabetes
- Inflammation, Proteolysis and IL-1 Beta Receptor Inhibition in Chronic Hemodialysis Patients
- Study to Prevent Cartilage Damage Following Acute Knee Injury.
- The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria
- REKinDLE: Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations
- Evaluating Kineret® (Anakinra) in Rheumatoid Arthritis (RA) Subjects Using aSelf-Reported Questionnaire
- Anakinra (Kineret®) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA)
- Interleukin-1 Trap to Treat Autoinflammatory Diseases
- Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease
Clinical trials list
click for details